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ABSTRACT
Periodontitis is one of the most widespread infectious dis-
eases in humans. It is the main cause of tooth loss and
associated with a number of systemic diseases. Until now,
there is no appropriate method for functional periodontal
tissue regeneration. Here, we establish a novel approach
of using allogeneic periodontal ligament stem cells
(PDLSCs) sheet to curing periodontitis in a miniature pig
periodontitis model. Signiﬁcant periodontal tissue regen-
eration was achieved in both the autologous and the allo-
geneic PDLSCs transplantation group at 12 weeks post-
PDLSCs transplantation. Based on clinical assessments,
computed tomography (CT) scanning, and histological ex-
amination, there was no marked difference between the
autologous and allogeneic PDLSCs transplantation
groups. In addition, lack of immunological rejections in
the animals that received the allogeneic PDLSCs trans-
plantation was observed. Interestingly, we found that
human PDLSCs fail to express human leukocyte antigen
(HLA)-II DR and costimulatory molecules. PDLSCs were
not able to elicit T-cell proliferation and inhibit T-cell
proliferation when stimulated with mismatched major
histocompatibility complex molecules. Furthermore, we
found that prostaglandin E2 (PGE2) plays a crucial role
in PDLSCs-mediated immunomodulation and periodontal
tissue regeneration in vitro and in vivo. Our study dem-
onstrated that PDLSCs possess low immunogenicity and
marked immunosuppression via PGE2-induced T-cell
anergy. We developed a standard technological procedure
of using allogeneic PDLSCs to cure periodontitis in
swine. STEM CELLS 2010;28:1829–1838
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INTRODUCTION
Periodontitis is one of the most widespread infectious diseases
in humans. It is the main cause of tooth loss and is associated
with a number of systemic diseases such as diabetes and cardi-
ovascular disease [1]. Thus far, no appropriate method has
been developed to provide functional and predictable periodon-
tal tissue regeneration. Several regenerative approaches, includ-
ing guided tissue regeneration, application of enamel matrix de-
rivative, and various growth factors, were proposed to treat
periodontal disease and acquired favorable results in clinical
trials and animal models [2–5]. Recently, the identiﬁcation of
periodontal ligament stem cells (PDLSCs) and other tooth-
related stem cells has provided new prospect and appropriate
cell sources for periodontal tissue regeneration [6–8]. Previ-
ously, we generated periodontitis in swine model, and we have
used autologous PDLSCs to cure periodontitis with signiﬁcant
periodontal tissue regeneration in swine [9, 10]. However, sour-
ces of autologous PDLSCs are limited, particularly for aged
patients, largely impeding the clinical application of this
approach. Thus, it is critical to develop a feasible allogeneic
cell-based method for the treatment of periodontitis.
In the present study, we have generated a periodontitis
model and transplanted cell sheets derived from allogeneic
PDLSCs for the treatment of periodontitis in miniature pigs. In
addition, we have assessed immunogenicity and immunomodu-
lation of human PDLSCs (hPDLSCs) and miniature pig
PDLSCs (pPDLSCs) and investigated their contribution to
PDLSC-mediated therapies. Our data demonstrate that alloge-
neic pPDLSC sheets are able to provide appropriate therapy for
periodontitis with signiﬁcant periodontal tissue regeneration
and low immunogenicity. We have developed a standard tech-
nological procedure for the potential application of allogeneic
PDLSCs in the treatment of periodontitis-induced bone defects.
MATERIALS AND METHODS
Antibodies
Antibodies used in this study are described in the Supporting In-
formation Materials and Methods.
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This study was reviewed and approved by the Animal Care and
Use Committee of Capital Medical University. Female Wuz-
hishan and male Guizhou inbred miniature pigs (minipig; 6- to 8-
months old, weighing 30–40 kg) were obtained from the Institute
of Animal Science of the Chinese Agriculture University. Mini-
pigs were kept under conventional conditions with free access to
water and a regular supply of soft food. Minipig PDLSCs
(pPDLSCs) were isolated from canine and cultured as described
previously [9]. We seeded 1.0   10
6 pPDLSCs onto 100-mm cul-
ture dishes. On conﬂuency, 40 mg of hydroxyapatite/tricalcium
phosphate (HA/TCP; Biomedical Materials and Engineering Cen-
ter of Wuhan University of Technology, Wuhan, China, http://
www.whut.edu.cn) were added, and the cells were cultured for
several days to obtain the cell sheets naturally formed when
pPDLSCs proliferate in the presence of HA/TCP. Two cell sheets
were used to repair one defective area. We generated periodonti-
tis lesions in 15 female Wuzhishan inbred minipigs as previously
reported [9], for a total of 30 defects. These defects were ran-
domly assigned to ﬁve groups: (a) control group (six defects in
three minipigs) with initial periodontal therapy only; (b) HA/TCP
group (six defects in three minipigs), in which the defects were
treated with ﬂap surgery, transplantation of HA/TCP scaffolds,
and covering of the defects with gelatin membranes (Nangjing
Jingling Medical Co., Nanjing, China, http://www.jlpharm.com);
(c) HA/TCP scaffolds þ autologous pPDLSCs group (six defects
in three minipigs), in which the defects were treated with ﬂap
surgery, transplantation of autologous pPDLSC sheets combined
with HA/TCP scaffolds, and covering of the defects with gelatin
membranes; (d) HA/TCP scaffolds þ allogeneic Guizhou minipig
pPDLSCs group (six defects in three minipigs), in which the
defects were treated with ﬂap surgery, transplantation of an allo-
geneic male Guizhou minipig pPDLSC sheet combined with HA/
TCP scaffolds, and covering of the defects with gelatin mem-
branes; (e) HA/TCP scaffolds þ autologous heterogenic minipig
periodontal ligament cells (pPDLCs) group (six defects in three
minipigs), in which the defects were treated with ﬂap surgery,
transplantation of autologous pPDLCs sheets combined with HA/
TCP scaffolds, and covering of the defects with gelatin mem-
branes. A schematic illustration of the time line of the procedures
conducted for this study is presented in Supporting Information
Figure 1.
Clinical Assessment of Periodontal Tissue
Regeneration
Clinical assessments, including probing depth, gingival recession,
and attachment loss, were measured on all experimental teeth
prior to the generation of the periodontitis models (week  4),
prior to the treatment (week 0), and 12 weeks post-transplanta-
tion. Routine blood tests (white blood cells, red blood cells, plate-
lets, and the concentration of hemoglobin), routine biochemical
tests (aspartate aminotransferase, alanine aminotransferase, total
protein, blood urea nitrogen, and creatinine), immunoglobulin
(IgE, IgG, IgA, IgM), and T cell-related markers (percentage of
CD3
þ cells, CD4
þ cells, CD8
þ cells, and the expression of the
activated T-cell marker CD40L) were examined at week  4 and
at 1–7 days, 2 weeks, 4 weeks, 8 weeks, and 12 weeks post-
transplantation.
Imaging and Histological Assessments
Bone regeneration was examined by computed tomography (CT;
Siemens, Germany, http://www.medical.siemens.com) scanning
upon transplantation (week 0) as well as 12 weeks post-transplan-
tation. At 12 weeks post-transplantation, all animals were sacri-
ﬁced; samples from the experimental areas were harvested, ﬁxed
with 4% formaldehyde, decalciﬁed with 10% EDTA (pH 8.0),
and embedded in parafﬁn. Sections (5 lm) were deparafﬁnized
and stained with H&E. For quantiﬁcation of bone formation, the
extent of bone within each section was analyzed semiquantita-
tively by histomorphometric techniques as described previously
[11]. Ten representative areas at  5 magniﬁcation in each group
were used. The area of bone formation was expressed as the per-
centage of bone in the periodontium in the sections.
Cell Tracing in Regenerated Periodontal Tissues
Details of the immunoﬂuorescent assays were described in Sup-
porting Information Materials and Methods.
Quantitative Reverse Transcription Polymerase
Chain Reaction
Quantitative reverse transcription polymerase chain reaction (RT-
PCR) assays for hepatocyte growth factor, transforming growth
factor b1, interleukin (IL)-10, and cyclooxygenase 2 (COX-2) are
described in the Supporting Information Materials and Methods.
Human PDLSCs and Heterogenic PDLCs
All protocols for the handling of human tissue were approved by
the Research Ethical Committee of Capital Medical University,
China. Isolation and culture of human PDLSCs [6] and hetero-
genic periodontal ligament cells (hPDLCs) are performed as pre-
vious report [12]. All cells used in this study were at 3–4 pas-
sages. For each experiment, the same passages hPDLSCs and
hPDLSc were used.
Peripheral Blood Mononuclear Cells
Peripheral blood mononuclear cells (PBMCs) from healthy donors
were obtained by gradient centrifugation separation method. In
brief, 10 ml fresh heparinized peripheral blood was diluted with
an equal volume of phosphate buffered saline (PBS). Five millili-
ters of diluted blood was carefully layered on 5 ml Ficoll (1.077
g/ml; Dingguo, Beijing, China, http://www.dingguo.com) for cen-
trifugation at 900g for 30 minutes. The PBMCs layer was sepa-
rated and washed with ﬁve volumes of PBS for three times, and
precipitated cells were resuspended in Roswell Park Memorial
Institute (RPMI)-1640 medium (GIBCO, Carlsbad, CA, http://
www.invitrogen.com) containing 10% FBS, 20 mol/l HEPES, 2
mmol/l glutamine, 100 U/ml penicillin, and 100 lg/ml streptomy-
cin (Invitrogen).
Flow Cytometry Analysis of Cell Surface Markers
To characterize the expression proﬁles of surface molecules,
hPDLSCs were harvested, and cell aliquots (1.0   10
6 cells)
were incubated with monoclonal antibodies against HLA-I, HLA-
II DR, CD80, CD86, STRO-1, CD90, or CD146 for 1 hour at
room temperature. After washing with PBS, the cells were incu-
bated with ﬂuorescein isothiocyanate-conjugated goat anti-mouse
IgG, M, A antibodies for 30 minutes in the dark at room tempera-
ture. Antibodies were used in the concentrations suggested by the
manufacturers. The expression proﬁles were analyzed by ﬂuores-
cein-activated cell sorter Calibur ﬂow cytometry (BD Inmmuno-
cytometry Systems, San Jose, CA, http://www.bd.com).
Multipotent Differentiation
Multilineage differentiation assays toward osteogenic and adipo-
genic pathways were performed as previously reported [10]. To
detect osteogenic differentiation, calciﬁcation of the extracellular
matrix was checked via von Kossa staining. Oil red O staining
was used to identify lipid-laden fat cells.
Immune Assays
5.0   10
4 hPDLSCs and hPDLCs were irradiated (20 Gy; Varian,
Palo Alto, CA, http://www.varianinc.com) before being cultured
with allogeneic T cells. Then, hPDLSCs/hPDLCs and an equal
number of PBMCs were cocultured in triplicate in a 96-well U-
bottomed plate for 5 days in 0.2 ml RPMI-1640 (GIBCO, Carls-
bad, CA, http://www.invitrogen. com). The plates were pulsed
with 1 lCi/well
3H-thymidine (
3H-TdR; Chinese Institute of
Atomic Energy, Beijing, China, http://www.ciae.ac.cn) 18 hours
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and
3H-TdR incorporation was measured using a liquid scintilla-
tion counter (Wallsc, PerkinElmer, Wellelsy, MA, http://
www.perkinelmer.com). Results of
3H-TdR incorporation are pre-
sented as mean counts per minute 6 SD.
A mitogen proliferative assay was used to assess the effect of
hPDLSCs/hPDLCs on T-cell proliferation. PBMCs (5.0   10
4)
stimulated by 0.5 lg/ml phytohemagglutinin (PHA; Sigma-
Aldrich, St Louis, MI, http://www.sigma-aldrich.com) were mixed
at various stimulator-responder ratios with autologous hPDLSCs/
hPDLCs; 1.0   10
4, 5.0   10
4, 2.5   10
5, and 5.0   10
5
hPDLSCs/hPDLCs were added. A total of 1 lCi
3H-TdR was
added into each well 18 hours prior to harvesting. The cells were
harvested on day 5 and
3H-TdR incorporation was measured as
described earlier.
To evaluate delayed addition of hPDLSCs/hPDLCs affected
T-cell proliferation, hPDLSCs/hPDLCs (5.0   10
4) were added
in a 1:1 ratio to 2-day-old cultures of PBMCs stimulated by 0.5
lg/ml PHA. Prior to the last 18 hours of three additional culture
days, 1 lCi
3H-TdR was added to the wells, followed by cell har-
vesting and measurement of
3H-TdR incorporation.
To study the effects of hPDLSCs/hPDLCs on a two-way
mixed lymphocyte reaction (MLR), hPDLSCs/hPDLCs from the
third person (third-party) were added at the beginning of the
experiments in a ﬁnal volume of 0.2 ml RPMI-1640. PBMCs (5.0
  10
4) from two individuals were incubated with an equal num-
ber of hPDLSCs/hPDLCs from third party. The proliferation of
responder cells was assessed after 5 days; the cells were pulsed
during the last 18 hours with
3H-TdR (1 lCi/well). The harvest-
ing of cells and the measurement of
3H-TdR incorporation were
carried out as described earlier.
Restimulation of T cells Following Culture
with hPDLSCs
To test whether the hPDLSC-induced effect on T-cell prolifera-
tion was reversible, PBMCs (5.0   10
4) were initially incubated
with an equal number of hPDLSCs and 0.5 lg/ml PHA for 5
days. T cells were harvested and cultured with PHA (0.5 lg/ml)
or recombinant human IL-2 (50 U/ml; R&D systems, Minneapo-
lis, MN, http://www.rndsystems.com). After 2 days, the cells
were pulsed with
3H-TdR for further 18 hours, followed by mea-
surement of
3H-TdR incorporation.
Transwell Cultures
Transwell chambers with a 0.4-lm pore size membrane (Costar,
Cambridge, MA, http://www.corning.com) were used to physi-
cally separate the PBMCs from the hPDLSCs. PBMCs (5.0  
10
4) were seeded with PHA (0.5 lg/ml) in the upper chamber,
and hPDLSCs (5.0   10
4) were placed in the bottom chamber.
After 5 days of coculture, T cells were harvested, placed in 96-
well plates, and pulsed with
3H-TdR for further 18 hours to mea-
sure the
3H-TdR incorporation.
Measurement of Soluble Factors and
Neutralization Assay
Enzyme-linked immunosorbent assays (ELISAs) were used to
quantify HGF, TGF-b1, prostaglandin E2 (PGE2), and IL-10.
Then, neutralizing monoclonal antibodies or inhibitors against
speciﬁc soluble factors were added to a coculture containing
PBMCs (5.0   10
4), hPDLSCs (5.0   10
4), and PHA (0.5 lg/ml)
in Transwell chambers. Experimental details were described in
the Supporting Information Materials and Methods.
Foxp31 T-Cell Measurement
Flow cytometry was used to determine the percentage of Foxp3þ
T cells at 5 days post coculture with PBMCs (5.0   10
4) and
PHA (0.5 lg/ml) or coculture with PBMCs (5.0   10
4), PHA
(0.5 lg/ml), and allogeneic hPDLSCs (5.0   10
4).
Determination of the Percentage of Apoptotic
T Cells
The percentage of apoptotic T cells at 5 days postculture with
hPDLSCs and PHA was evaluated using the Annexin V-Fluos
staining kit (Roche Diagnostics, Penzberg, Germany, http://
www.roche-applied-science.com) according to the manufacturer’s
instructions.
Statistical Analysis
Statistical signiﬁcance was assessed by two-tailed Student’s t-test
or analysis of variance; a p value less than .05 was considered
statistically signiﬁcant.
RESULTS
Allogeneic PDLSC-Mediated Therapy
for Periodontitis
We developed a cell-based procedure for using allogeneic
PDLSCs to treat periodontitis (Fig. 1A). PDLSCs were iso-
lated from minipig canines or normal human impacted third
molars and cultured to the third passage for use. The number
of hPDLSCs and pPDLSCs from one tooth (P3) was 8.86 6
0.46   10
6 (n ¼ 10) and 8.23 6 0.68   10
6 (n ¼ 10), respec-
tively. In this study, we utilized ﬂow cytometry to indicate
that PDLSCs were positive for STRO-1, CD146, which only
expressed in early progenitors of culture expanded mesenchy-
mal stem cells [6–8, 10, 13, 14]. In addition, hPDLSCs
expressed positive mesenchymal stem cell-associated markers
CD90 [15]. Osteogenic differentiation of hPDLSCs was
detected by nodular structures formation stained black via von
Kossa staining, indicating calcium accumulation in vitro.
PDLSCs were also found to possess the potential to develop
into Oil red O-positive lipid-laden fat cells following 4 weeks
of culture with an adipogenic-inductive medium (Fig. 1B).
Cryopreservation did not affect the biological and immuno-
logical properties of the PDLSCs (data not shown), the same
as human apical papilla stem cells [16]. To prepare the
PDLSC sheet, 1   10
6 PDLSCs were cultured in a 100-mm
culture dish for 15 days, and then 40 mg HA/TCP particles
were added to the dishes to increase plasticity of the cell-scaf-
fold mixture (Fig. 1Ae, 1Af, 1Ag). After a surgical procedure
to remove infectious periodontal tissues (Fig. 1Ah, 1Ai), allo-
geneic PDLSC sheet (with intact cell-cell junctions and de-
posited extracellular matrix) was applied to the periodontal
defective areas for tissue regeneration (Fig. 1Aj).
After generating minipig periodontitis model [9], alloge-
neic pPDLSCs sheet was transplanted into the periodontitis
lesion areas (Supporting Information Fig. 1). At 12 weeks
post-transplantation, the probing depth (PD) was 3.5 6 0.6
mm in the allogeneic pPDLSCs group, 3.3 6 0.4 mm in the
autologous pPDLSCs group, 13.1 6 1.1 mm in the HA/TCP
group, 10.6 6 1.3 mm in the control group, and 6.2 6 0.7
mm in the autologous pPDLCs group. Statistical analysis indi-
cated that both the autologous and allogeneic pPDLSCs treat-
ments signiﬁcantly improved periodontal tissue regeneration
compared with the pPDLCs group, HA/TCP and control
groups, with no difference between the autologous and alloge-
neic pPDLSCs groups (Figs. 2, 3).
Intraoral photographs indicated that 12 weeks after trans-
plantation, pPDLSC-mediated periodontal tissue regeneration
was close to normal level (Fig. 2C, 2D). Only limited or par-
tial periodontal tissue was regenerated in the control group
(Fig. 2A), HA/TCP group (Fig. 2B), and pPDLCs group (Fig.
2E). CT scanning showed that the height of the alveolar bone
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ered to almost normal levels. There was some new bone
regeneration in the pPDLCs group, which was fewer than in
the autologous and allogeneic pPDLSCs groups. However, the
HA/TCP group and the control group showed little alveolar
bone recovery (Fig. 2F–2J). In addition, histopathological
photomicrographs indicated that new bone, cementum, and
periodontal ligament were regenerated to normal levels in
both the autologous and allogeneic pPDLSCs groups. In con-
trast, deep periodontal pockets along with bone and periodon-
tal ligament defects were observed in the HA/TCP and control
groups (Fig. 2K–2Y). These data indicate that a cell sheet
from 2   10
6 pPDLSCs could successfully regenerate peri-
odontal bone defects of 3 mm   5m m  7 mm in size (a
sheet of 10
6 pPDLSCs for an approximately 50 mm
3 peri-
odontal bone defect). The percentages of periodontium bone
in the autologous and allogeneic pPDLSCs groups were
38.6% 6 2.3% and 35.7% 6 2.8%, respectively, which were
signiﬁcantly higher than those in the pPDLCs group (18.9%
6 3.3%), the control (10.1% 6 2.2%), and HA/TCP (8.3% 6
1.9%) groups (Fig. 2Z, a). Immunoﬂuorescent assays revealed
positive staining of Y chromosomes in the allogeneic
pPDLSCs transplantation group (Fig. 2Z, c), compared with
negative Y chromosome staining in the autologous pPDLSCs
transplantation group (Fig. 2Z, b). To test the immunological
reaction induced by allogeneic pPDLSC transplantation, we
analyzed T cell-related immunological markers (Fig. 4), rou-
tine blood and biochemical tests, and immunoglobulin tests
(data not shown) in whole blood. There were no signiﬁcant
differences between allogeneic and autologous PDLSCs
groups based on the analysis of the samples, suggesting there
were no immunological rejections in the animals that received
transplantation of allogeneic pPDLSCs.
PDLSCs Inhibit T Cell Proliferation Through PGE2
In vitro study revealed that hPDLSCs (76.2% 6 5.8%, n ¼ 5)
expressed human leukocyte antigen (HLA)-I, but were
Figure 1. A standard procedure for the application of allogeneic PDLSCs in the treatment of periodontitis and characterization of PDLSCs.
(A): (a) Collection of PDL. Normal impacted third molars were collected from patients aged 18–28 years. PDL was gently separated from the
root surface. (b) Culture of PDLSCs. PDLSCs were isolated as previously reported. Fifteen days after primary culture, the number of PDLSCs
from one impacted third molar was approximately 4.90 6 0.34   10
5 (P0; n ¼ 10). Following another 15-day culture, the number of PDLSCs
(P3) increased to 8.86 6 0.46   10
6 (n ¼ 10). (c) Cryopreservation of PDLSCs. Third-passage PDLSCs were cryopreserved with 10% DMSO
and 90% FBS and stored in liquid nitrogen. (d) PDLSCs thawing. After thawing, PDLSCs were examined for mycoplasma, bacteria, colony-form-
ing efﬁciency, proﬁles of mesenchymal stem cell markers, and karyotype. (e) Preparation of PDLSC sheet. Three different cell amounts (1  
10
5,1  10
6, and 2   10
6, n ¼ 3) were cultured for 12–15 days in 100-mm culture dishes; cell sheets formed in the 1   10
6 and 2   10
6 groups
but not in the 1   10
5 group. Therefore, 1   10
6 PDLSCs were seeded into 100-mm culture dishes for 15 days. (f) Forty milligrams of HA/TCP
was added to the cultures. (g) The whole view of the PDLSC sheet with HA/TCP. (h) Buccal view of periodontitis lesion. After initial periodon-
tal therapy (i), two allogeneic PDLSC sheets with HA/TCP were transplanted to a periodontal lesion sized 3 mm   5m m  7 mm (j). (k)
Follow-up included clinical and radiographic assessments and hematological and immunological evaluations. (B): PDLSCs were positive for
STRO-1, CD146, CD90 and could advance into osteogenic and adipogenic differentiation under inductive medium. Abbreviations: HA/TCP,
hydroxyapatite/tricalcium phosphate; PDL, periodontal ligament; PDLSC, periodontal ligament stem cell.
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and CD86 (Fig. 5A). To investigate the function of hPDLSCs
as antigen-presenting cells in T-cell proliferation, preirradiated
(20 Gy) hPDLSCs were cocultured with allogeneic normal
PBMCs at a ratio of 1:1. These preirradiated hPDLSCs failed
to stimulate allogeneic T-cell proliferation, whereas the allo-
geneic PBMCs triggered vigorous T-cell proliferation in the
responder PBMCs. Moreover, hPDLCs could elicit low-grade
T-cell proliferation, but signiﬁcantly lower than allogeneic
PBMCs (Fig. 5B). These results indicated that hPDLSCs dis-
played low immunogenicity. To determine whether hPDLSCs
affect normal T-cell proliferation triggered by mitogen and al-
loantigen, various numbers of hPDLSCs (1.0   10
4, 5.0  
10
4, 2.5   10
5, or 5.0   10
5) were cocultured with autolo-
gous PBMCs (5.0   10
4) stimulated by PHA (0.5 lg/ml).
PHA-induced T-cell proliferation was signiﬁcantly inhibited
Figure 2. Regeneration of periodontitis defects mediated by allogeneic miniature pig PDLSCs (pPDLSCs). (A–E): Intraoral photographs indi-
cated that 12 weeks after transplantation, autologous (C) or allogeneic (D) pPDLSC-mediated periodontal tissue regeneration was close to normal
level. Only limited periodontal tissues were regenerated in the control group (A), HA/TCP group (B), and partially regenerated periodontal tissues
in pPDLCs group (E). CT images showed that limited bone formation was found in the control group (F) and the HA/TCP group (G) 12 weeks
after pPDLSC transplantation. Autologous pPDLSCs (H) or allogeneic pPDLSCs (I) mediated nearly complete alveolar bone regeneration. (K–
Y): HE staining showed new periodontal tissue regeneration in the periodontal defect area in autologous (Q) and allogeneic (T) pPDLSC groups.
However, deep periodontal pockets and shortages of new bone and periodontal ligament ﬁbers remained in the control (K) and HA/TCP groups
(N). The alveolar bone heights in the autologous (Q) and allogeneic (T) pPDLSC groups were much larger than those in the control group (K),
the HA/TCP group (N), and PDLCs group (W). Much thicker sulcular epithelia and enlarged epithelial pegs were evident in the control group
(L), the HA/TCP group (O), and PDLCs group (X) compared with the autologous (R) and allogeneic (U) pPDLSC groups. Sharpy’s ﬁbers
formed in the autologous (S) and allogeneic (V) pPDLSC groups, but typical Sharpy’s ﬁbers were not found in the control group (M), the HA/
TCP group (P), or PDLCs group (Y). (Z): (a) The percentage of periodontal bone in the autologous and allogeneic pPDLSC groups was signiﬁ-
cantly higher than those of the control group, HA/TCP group, and PDLCs group. (b) No positive staining of Y chromosomes was detected in the
autologous pPDLSC group. (c) Positive staining of Y chromosomes was found in alveolar bone close to the PDL in the allogeneic pPDLSC
group, indicating that regenerated periodontal tissues differentiated from allogeneic pPDLSCs. ‘‘D’’ indicates dentin, ‘‘C’’ indicates cementum,
and ‘‘B’’ indicates bone (K–W). (A, F, K, L, M): Control group without HA/TCP implantation, (B, G, N, O, P): HA/TCP group, (C, H, Q, R,
S): autologous pPDLSC group, (D, I, T, U, V): allogeneic pPDLSC group, and (E, J, W, X, Y): autologous PDLCs group. The ﬁgures in the
upper-right section of (F–J) are the coronal images of miniature pigs. Scale bar ¼ 1m m(K, N, Q, T, W); Scale bar ¼ 5 lm( [Z], b, c). #, p <
.01, compared with autologous PDLCs groups; *, p < .01, compared with autologous and allogeneic PDLSCs groups. Abbreviations: CEJ,
cemeto-enamel junction; HA/TCP, hydroxyapatite/tricalcium phosphate; HAB, height of alveolar bone; PDL, periodontal ligament; PDLSC, peri-
odontal ligament stem cell; SE, sulcular epithelium.
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bers of autologous PBMCs showed no inhibitory effects, indi-
cating that immunosuppression of T-cell proliferation was
speciﬁcally attributable to hPDLSCs (Fig. 5C). Strikingly,
hPDLSCs are capable of signiﬁcantly suppressing T-cell pro-
liferation when added into the culture dishes 2 days post-PHA
stimulation (Fig. 5D). When two-way MLR was performed by
coculture of PBMCs derived from two individuals and
hPDLSCs collected from a third party, a cell number-depend-
ent hPDLSCs inhibitory effect was found on PBMCs sub-
jected to allogeneic PBMCs stimulation (Fig. 5E). In addition,
whether added at day 0 or day 2, hPDLCs could also suppress
the PHA-induced T-cell proliferation and two-way MLR,
however, signiﬁcantly lower than hPDLSCs. Taken together,
these results indicate that hPDLSCs suppress allogeneic T-cell
receptor-triggered or mitogen-stimulated T-cell proliferation
in a cell number-dependent and antigen nonspeciﬁc manner,
and their capability is higher than hPDLCs.
PGE2 Plays a Crucial Role in PDLSCs-Mediated
T-Cell Suppression
We next explored mechanisms by which hPDLSCs suppress
T-cell proliferation. To examine whether cell-cell contact was
required for inhibition, a Transwell culture system was used
to separate PHA-treated PBMCs from hPDLSCs. We found
that T-cell proliferation was equally inhibited by cell-cell con-
tact culture and the Transwell culture, suggesting that inhibi-
tion was independent of cell-cell contact and might involve in
soluble factor(s) (Fig. 6A). As IL-10, HGF, TGF-b1, and
PGE2 play important roles in bone marrow mesenchymal
stem cell (BMMSC)-mediated T-cell immunosuppression [17–
20], we used ELISA to quantify these four soluble factors in
the culture supernatants of hPDLSCs and hPDLSCs cocul-
tured with PHA-treated PBMCs. HGF and IL-10 were not
detected in the supernatant of either hPDLSCs alone or the
coculture. Kinetic studies revealed that the concentrations of
TGF-b1 and PGE2 in the culture of hPDLSCs alone (1–5
days after seeding) were relatively stable (Fig. 6B, 6C). How-
ever, the supernatants from the coculture group contained
PGE2 that were signiﬁcantly elevated compared with those in
hPDLSC group (Fig. 6C). The concentration of TGF-b1 was
not signiﬁcantly altered compared with the control group (Fig.
6B).
To pinpoint the identity of the factor(s) involved in immu-
nosuppression, speciﬁc monoclonal antibodies against TGF-b,
IL-10, and HGF, or the PGE2 inhibitor indomethacine, were
added into coculture containing hPDLSCs, PBMCs, and PHA,
and the restoration of T-cell proliferation was assessed. Only
indomethacine restored the T-cell proliferation inhibited by
hPDLSCs; the neutralizing monoclonal antibodies against
TGF-b, IL-10, and HGF failed to restore T-cell proliferation
(Fig. 6D). The percentage of Foxp3þ T cells in coculture of
PBMCs and PHA (Fig. 6E) was similar to that in coculture of
PBMCs, PHA, and hPDLSCs (Fig. 6F), indicating that TGF-
b-induced active immunoregulation of regulatory T cells did
not involve this immunosuppression. In addition to these in
vitro data, real-time PCR assays showed that the expression
of COX-2, a major enzyme in the biosynthesis of PGE2, was
signiﬁcantly increased in regenerated periodontal tissues of
the allogeneic pPDLSC transplantation group, while the
expressions of TGF-b1, HGF, and IL-10 were unchanged at
2 weeks post-transplantation (Fig. 6G). Taken together, our
data suggest that PGE2 is a key inhibitor of T-cell prolifera-
tion mediated by PDLSCs. Moreover, we observed no differ-
ence in the number of apoptotic T cells between the cocul-
ture group containing PBMCs, PHA, and hPDLSCs, and the
PHA-induced T-cell proliferation group; the majority of the
T cells were viable, excluding T cell death as the major
cause for the suppression (Fig. 6H, 6I), as previously
reported [21]. In addition, we isolated T cells presuppressed
by hPDLSCs for 5 days and restimulated with either PHA or
IL-2 for another 2 days. We found that restimulation of T
cells pretreated with hPDLSCs resulted in vigorous prolifera-
tion (restored to normal levels, Fig. 6J). Thus, hPDLSC-
induced inhibition of T-cell proliferation is reversible in an
anergic manner.
DISCUSSION
Given their capacity to modulate immune responses,
BMMSCs have been implicated as a potentially feasible treat-
ment approach for several diseases, such as graft-versus-host
disease [22] and autoimmune diseases [23, 24]. The wide use-
fulness of BMMSCs can be attributed to their low immunoge-
nicity and immunomodulation function. Recently, it was rec-
ognized that PDLSCs are a potential therapeutic cell source
for tooth regeneration and reconstruction of periodontal liga-
ment damaged by periodontal diseases [6, 9, 10]. The purpose
of investigating immunogenicity and immunomodulation
property of PDLSCs is to explore the allogeneic usefulness of
PDLSCs in clinical application.
Initially, we observed similar biological and immunologi-
cal properties in hPDLSCs and pPDLSCs (data not shown)
[9]. Because of availability of antibodies to hPDLSCs and
clinical application potential, hPDLSCs were selected for
immunological analysis in vitro in this study. We have shown
that hPDLSCs do not express HLA-II DR or costimulatory
molecules and fail to elicit T-cell proliferation. This may con-
tribute to the fact that hPDLSCs display low immunogenicity.
To test the immunomodulation functions of hPDLSCs, we
investigated the effects of hPDLSCs on PHA-induced alloge-
neic T-cell proliferation and on two-way MLR. hPDLSCs in-
hibit T cells in a dose-dependent manner both in a mitogen
proliferative assay and in two-way MLR, indicating that
PDLSCs inhibit the T-cell proliferation stimulated by
Figure 3. Clinical assessment of regeneration of periodontal tissues.
At  4 week and 0 week, there was no signiﬁcant difference among
the ﬁve groups. However, 12 weeks post-transplantation, the PD, GR,
and AL were signiﬁcantly improved in autologous pig PDLSCs
(pPDLSCs) or allogeneic pPDLSCs group than those in the control
group, HA/TCP group, and autologous PDLCs group. *, p < .01,
compared with autologous and allogeneic PDLSCs groups; #, p <
.01, compared with autologous PDLCs groups. Abbreviations: AL,
attachment loss; GR, gingival recession; HA/TCP, hydroxyapatite/tri-
calcium phosphate; PD, probing depth; PDLSC, periodontal ligament
stem cell.
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Moreover, T-cell proliferation induced by PHA was also sup-
pressed by delayed addition of hPDLSCs, suggesting that
hPDLSCs immunosuppress activated T cells analogous to
dental root apical papilla stem cells [25]. In addition, although
weaker than hPDLSCs, hPDLCs also possessed immunomo-
dulatory effect, which were correspondent with the data on
human synovial ﬁbroblasts, dermal ﬁbroblasts, lung-derived
ﬁbroblast, etc [26, 27].
In previous studies, BMMSC-mediated immune suppres-
sion of activated T cells has been attributed to the secretion
of antiproliferative soluble factors, such as IL-10, HGF, TGF-
b1, and PGE2, even though contradictory results render
unclear data regarding which factors play major roles in the
process [17–20]. T cell-mediated immunity is considered to
be one of the critical factors in pathogenesis of periodontitis
[28]. We have demonstrated that hPDLSCs suppress T-cell
proliferation via PGE2 in vitro. In addition, real-time PCR
assays showed that the expression of COX-2, a major enzyme
in the biosynthesis of PGE2, was signiﬁcantly increased in
regenerated periodontal tissues of the allogeneic pPDLSC
transplantation group, while the expressions of TGF-b1, HGF,
and IL-10 were unchanged at 2 weeks post-transplantation.
Taken together, PGE2 is considered to play a crucial role in
PDLSC-mediated immunomodulation and periodontal tissue
regeneration.
The oral maxillofacial region of the minipig is similar to
that of humans in anatomy, development, physiology, patho-
physiology, and disease occurrence [29]. Thus, the minipig is
a useful large animal model for dental orofacial research,
including immunological studies. Here, we generated perio-
dontitis lesions in the minipig, then tested the feasibility of
using an allogeneic PDLSC sheet to repair the periodontitis-
induced bone defects. As the typical immune response occur
within 3 months post-transplantation based on previous stud-
ies of stem cell-induced immune responses [30, 31], we
examined tissue regeneration and immune reaction for a pe-
riod of 12 weeks following transplantation. We found that the
allogeneic PDLSCs contributed to periodontal tissue repair in
a manner similar to the transplantation of autologous
PDLSCs. Additionally, we observed neither rejections nor
other damage in the allogeneic transplantation animals. How-
ever, the local immunological changes in the animals require
further study.
Figure 4. Dynamic evaluation of immunological parameters. (A): There were no signiﬁcant differences in the indicated time points regarding
the percentage of CD3
þ, CD4
þ, and CD8
þ T cells in the allogeneic pig PDLSC transplantation group. (B): The expression of CD4
þ and CD8
þ
T cells, as well as CD40L, a marker of activated T cells, were nearly identical among the four test groups 3 days post-transplantation. (C): The
percentage of CD4
þ and CD8
þ T cells and the expression of CD40L were also nearly identical among the four groups 12 weeks after transplan-
tation. Abbreviations: HA/TCP, hydroxyapatite/tricalcium phosphate; PDLSC, periodontal ligament stem cell.
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trol group without HA/TCP implantation was better than that
in HA/TCP control group. The reason responsible for this
phenomenon is not clear, may be associated with the recipient
immune response to HA/TCP. However, the exact causes
involved need further investigation.
Mesenchymal stem cells from other sources have been
used to enhance periodontal tissue regeneration [32–34].
Here, we isolated PDLSCs from extracted third molars, which
are usually regarded as a medical waste. Donor site morbidity
limits the amount of bone marrow available for treatment,
thereby extending the culture time is required to generate a
Figure 5. PDLSCs inhibit T-cell proliferation. (A): hPDLSCs were stained for immunological markers and analyzed by ﬂow cytometry, reveal-
ing positive expression of HLA-I but negative expression of HLA-II DR, CD80, and CD86. Data represent ﬁve independent experiments. (B): Co-
culture of T cells with hPDLSCs showed that hPDLSCs failed to stimulate allogeneic T-cell proliferation. *, p < .01, compared with group of
coculture of two allogeneic PBMCs; #, p < .01, compared with PDLCs groups. (C): T-cell proliferation stimulated by PHA in the presence or ab-
sence of hPDLSCs; the resulting inhibition was dose-dependent. *, p < .01, compared with PHA-stimulated PBMCs group; #, p < .01, compared
with PDLCs groups. (D): T-cell proliferation induced by PHA was inhibited by delayed addition of hPDLSCs. *, p < .01, compared with PHA-
stimulated PBMCs group; #, p < .01, compared with PDLCs groups. (E): A two-way mixed lymphocyte reaction (MLR) was inhibited by hPDLSCs
in a dose-dependent manner.*: p < .01, compared with MLR group; #, p < .01, compared with PDLCs groups. Data are presented as mean 6 SD
of triplicates of six independent experiments. Abbreviations: CPM, counts per minute; HLA, human leukocyte antigen; hPDLC, heterogenic peri-
odontal ligament cell; hPDLSC, human periodontal ligament stem cell; PBMC, peripheral blood mononuclear cell; PHA, phytohemagglutinin.
1836 Stem Cells for Periodontitis Treatmentlarge quantity for therapeutic use. PDLSCs harvested from
periodontal ligament show high proliferation rate when com-
pared with BMMSC and can differentiate into bone and soft
periodontal tissues in vivo. It is required to conduct a well-
designed study to compare the immunosuppressive and re-
generative effects of PDLSCs with other MSC type in the
future.
CONCLUSION
Our study demonstrated that a sheet of minipig PDLSCs can
repair allogeneic bone defects in an experimental model of
periodontitis without detected immunological rejections, likely
due to the low immunogenicity and immunosuppressive func-
tion possessed by PDLSCs. We developed a standard techno-
logical procedure for the application of allogeneic PDLSCs that
could be effective in the treatment of periodontitis-induced
bone defects.
ACKNOWLEDGMENTS
We express our sincere gratitude to Dr. Songtao Shi, Center for
Craniofacial Molecular Biology, University of Southern Califor-
nia School of Dentistry and Dr. Wanjun Chen, NIDCR, NIH,
USA, for their suggestions and critical reading of this article. This
work was supported by grants from the National Basic Research
Program of China (No.2007CB947304 and 2010CB944801 to
S.W.); the National Natural Science Foundation of China (Grants
Figure 6. Prostaglandin E2 (PGE2) is the key inhibitor of T-cell proliferation mediated by PDLSCs. (A): T-cell proliferation was signiﬁcantly
inhibited when cocultured with human PDLSCs (hPDLSCs) in the Transwell culture system and in cell-cell contact culture. (B): TGF-b1 levels
were similar between hPDLSCs alone and the coculture of hPDLSCs and PHA-induced T-cells. (C): The concentration of PGE2 signiﬁcantly
increased in the coculture of hPDLSCs and PHA-induced T cells. (D): The neutralizing monoclonal antibody against TGF-b failed to restore T-
cell proliferation, while the PGE2 inhibitor indomethacine restored T-cell proliferation. (E, F): The percentage of Foxp3
þ T cells in coculture of
PBMCs and PHA (E) was similar to that in coculture of PBMCs, PHA, and hPDLSCs (F). (G): The expression of COX2 was signiﬁcantly higher
in regenerated periodontal tissues of the allogeneic PDLSCs group than in the autologous PDLSCs group 2 weeks after transplantation, whereas
TGF-b1, HGF, and IL-10 levels did not change (n ¼ 4). (H, I): T-cell apoptosis rates were similar between PHA-stimulated T cells (I) and a co-
culture group with hPDLSCs (H). (J): Inhibition of T cell proliferation mediated by hPDLSCs was restored when T cells were restimulated by
PHA or IL-2. Data are presented as mean 6 SD of triplicates of six independent experiments. *, p < .01. Abbreviations: CPM, counts per mi-
nute; HGF, hepatocyte growth factor; hPDLSC, human periodontal ligament stem cell; PBMC, peripheral blood mononuclear cell; PDLSC, peri-
odontal ligament stem cell; PHA, phytohemagglutinin; TGF-b1, transforming growth factor b1.
Ding, Liu, Wang et al. 1837
www.StemCells.com30700941 and 30428009 to Y.L., S.W.), the Beijing Major Scien-
tiﬁc Program (D0906007000091 to S.W.), Beijing New Star Pro-
gram (2007B067 to Y.L.). The sponsors had no role in study
design, data collection and analysis, decision to publish, or prepa-
rationofthearticle.
DISCLOSURE OF POTENTIAL CONFLICTS
OF INTEREST
The authors indicate no potential conﬂicts of interest.
REFERENCES
1 Kinane DF, Marshall GJ. Periodontal manifestations of systemic dis-
ease. Aust Dent J 2001;46:2–12.
2 Kitamura M, Nakashima K, Kowashi Y et al. Periodontal tissue regen-
eration using ﬁbroblast growth factor-2: Randomized controlled phase
II clinical trial. Plos One 2008;3:e2611–e2622.
3 Nygaard-Østby P, Bakke V, Nesdal O et al. Periodontal healing fol-
lowing reconstructive surgery: Effect of guided tissue regeneration
using a bioresorbable barrier device when combined with autogenous
bone grafting. A randomized-controlled Trial 10-year follow-up.
J Clin Periodontol 2010;37:366–373.
4 Lee JS, Wikesjo ¨ UM, Jung UW et al. Periodontal wound healing/
regeneration following implantation of recombinant human growth/
differentiation factor-5 in a beta-tricalcium phosphate carrier into
one-wall intrabony defects in dogs. J Clin Periodontol 2010;37:
382–389.
5 Villar CC, Cochran DL. Regeneration of periodontal tissues: Guided
tissue regeneration. Dent Clin North Am 2010;54:73–92.
6 Seo BM, Miure M, Gronthos S et al. Investigation of multipotent post-
natal stem cells from human periodontal ligament. Lancet 2004;364:
149–155.
7 Gronthos S, Mankani M, Brahim J et al. Postnatal human dental pulp
stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA
2000;97:13625–13630.
8 Miura M, Gronthos S, Zhao M et al. SHED: Stem cells from human
exfoliated deciduous teeth. Proc Natl Acad Sci USA 2003;100:
5807–5812.
9 Liu Y, Zheng Y, Ding G et al. Periodontal ligament stem cell-medi-
ated treatment for periodontitis in miniature swine. Stem Cells 2008;
26:1065–1073.
10 Sonoyama W, Liu Y, Fang D et al. Mesenchymal stem cell-mediated
functional tooth regeneration in swine. Plos One 2006;1:e79–e92.
11 Shi S, Gronthos S, Chen S et al. Bone formation by human postnatal
bone marrow stromal stem cells is enhanced by telomerase expression.
Nat Biotechnol 2002;20:587–591.
12 Hasegawa M, Yamato M, Kikuchi A et al. Human periodontal liga-
ment cell sheets can regenerate periodontal ligament tissue in an athy-
mic rat model. Tissue Eng 2005;11:469–478.
13 Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem
cells in human bone marrow and dental pulp. J Bone Miner Res 2003;
18:696–704.
14 Sacchetti B, Funari A, Michienzi S et al. Self-renewing osteoprogeni-
tors in bone marrow sinusoids can organize a hematopoietic microen-
vironment. Cell 2007;131:324–336.
15 Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for deﬁn-
ing multipotent mesenchymal stromal cells. The International Society
For Cellular Therapy Position Statemen. Cytotherapy 2006;8:
315–317.
16 Ding G, Wang W, Liu Y et al. Effect of cryopreservation on biologi-
cal and immunological properties of stem cells from apical papilla. J
Cell Physiol 2010;223:415–422.
17 Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow
stromal cells suppress T-lymphocyte proliferation induced by cellular
or nonspeciﬁc mitogenic stimuli. Blood 2002;99:3838–3843.
18 Krampera M, Glennie S, Dyson J et al. Bone marrow mesenchymal
stem cells inhibit the response of naive and memory antigen-speciﬁc
T cells to their cognate peptide. Blood 2003;101:3722–3729.
19 Beyth S, Borovsky Z, Mevorach D et al. Human mesenchymal stem
cells alter antigen-presenting cell maturation and induce T- cell unre-
sponsiveness. Blood 2005;105:2214–2219.
20 Aggarwal S, Pittinger MF. Human mesenchymal stem cells modulate
allogeneic immune cell responses. Blood 2005;105:1815–1822.
21 Wada N, Menicanin D, Shi S et al. Immunomodulatory properties of
human periodontal ligament stem cells. J Cell Physiol 2009;219:
667–676.
22 Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe
acute graft-versus-host disease with third party haploidentical mesen-
chymal stem cells. Lancet 2004;363:1439–1441.
23 Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: A new
strategy for immunosuppression? Trends Immunol 2007;28:219–226.
24 Sun LY, Akiyama K, Zhang HY et al. Mesenchymal stem cell trans-
plantation reverses multiorgan dysfunction in systemic lupus erythem-
atosus mice and humans. Stem Cells 2009;27:1421–1432.
25 Ding G, Liu Y, Wang W et al. Suppression of T cell proliferation by
root apical papilla stem cells in vitro. Cells Tissues Organs 2010;191:
357–364.
26 Haniffa MA, Wang XN, Holtick U et al. Adult human ﬁbroblasts are
potent immunoregulatory cells and functionally equivalent to mesen-
chymal stem cells. J Immunol 2007;179:1595–1604.
27 Jones S, Horwood N, Cope A et al. The antiproliferative effect of
mesenchymal stem cells is a fundamental property shared by all stro-
mal cells. J Immunol 2007;179:2824–2831.
28 Gaffen SL, Hajishengallis G. A new inﬂammatory cytokine on the
block: Re-thinking periodontal diseases and the Th1/Th2 paradigm in
the context of Th17 cells and IL-17. J Dent Res 2008;87:817–828.
29 Wang S, Liu Y, Fang D et al. The miniature pig: A useful large ani-
mal model for dental and orofacial research. Oral Dis 2007;13:
530–537.
30 Yanez R, Lamana ML, Garcia-Castro J et al. Adipose tissue-derived
mesenchymal stem cells have in vivo immunosuppressive properties
applicable for the control of the graft-versus-host disease. Stem Cells
2006;24:2582–2591.
31 Kubo M, Sonoda Y, Muramatsu R et al. Immunogenicity of human
amniotic membrane in experimental xenotransplantation. Invest Oph-
thalmol Vis Sci 2001;42:1539–1546.
32 Kim SH, Kim KH, Seo BM et al. Alveolar bone regeneration by
transplantation of periodontal ligament stem cells and bone marrow
stem cells in a canine peri-implant defect model: A pilot study. J Peri-
odontol 2006;77:1003–1007.
33 Kawaguchi H, Hirachi A, Hasegawa N et al. Enhancement of peri-
odontal tissue regeneration by transplantation of bone marrow mesen-
chymal stem cells. J Periodontol 2004;75:1281–1287.
34 Li H, Yan F, Lei L et al. Application of autologous cryopreserved
bone marrow mesenchymal stem cells for periodontal regeneration in
dog. Cells Tissues Organs 2009;190:94–101.
Seewww.StemCells.comforsupportinginformationavailableonline.
1838 Stem Cells for Periodontitis Treatment